WT1 and acute myeloid leukemia: Of the 42 patients with inv (16), 7.14% (3/42) were in the high-risk group and 92.86% (39/42) were in the low-risk group (p < 0.001) (Figure 6A); WT1 mutation occurs in 6.85% (17/256) of AML patients and 13 of them were in the high-risk group (p = 0.04) (Figure 6A).